VanEck Pharmaceutical ETF Target of Unusually High Options Trading (NASDAQ:PPH)

VanEck Pharmaceutical ETF (NASDAQ:PPH) saw unusually large options trading activity on Thursday. Traders bought 7,698 put options on the stock. This is an increase of 2,233% compared to the average daily volume of 330 put options.

VanEck Pharmaceutical ETF Trading Up 2.2 %

Shares of VanEck Pharmaceutical ETF stock opened at $83.98 on Friday. The company has a market capitalization of $561.83 million, a P/E ratio of 24.31 and a beta of 0.72. The stock has a fifty day simple moving average of $89.40 and a 200 day simple moving average of $89.46. VanEck Pharmaceutical ETF has a 12-month low of $77.67 and a 12-month high of $99.51.

VanEck Pharmaceutical ETF Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, April 4th. Shareholders of record on Tuesday, April 1st were given a $0.5245 dividend. The ex-dividend date was Tuesday, April 1st. This represents a $2.10 annualized dividend and a yield of 2.50%. This is a boost from VanEck Pharmaceutical ETF’s previous quarterly dividend of $0.31.

Institutional Trading of VanEck Pharmaceutical ETF

Several hedge funds have recently added to or reduced their stakes in PPH. FMR LLC boosted its holdings in shares of VanEck Pharmaceutical ETF by 12.5% in the third quarter. FMR LLC now owns 1,905 shares of the company’s stock worth $181,000 after acquiring an additional 212 shares during the period. Stifel Financial Corp boosted its stake in VanEck Pharmaceutical ETF by 13.4% in the 3rd quarter. Stifel Financial Corp now owns 7,810 shares of the company’s stock worth $742,000 after purchasing an additional 924 shares during the period. Jane Street Group LLC grew its holdings in VanEck Pharmaceutical ETF by 124.0% during the 3rd quarter. Jane Street Group LLC now owns 19,436 shares of the company’s stock valued at $1,847,000 after buying an additional 10,759 shares in the last quarter. AAFMAA Wealth Management & Trust LLC increased its position in shares of VanEck Pharmaceutical ETF by 3.1% during the fourth quarter. AAFMAA Wealth Management & Trust LLC now owns 36,419 shares of the company’s stock valued at $3,142,000 after buying an additional 1,100 shares during the period. Finally, Mivtachim The Workers Social Insurance Fund Ltd. Under Special Management lifted its holdings in shares of VanEck Pharmaceutical ETF by 117.4% in the fourth quarter. Mivtachim The Workers Social Insurance Fund Ltd. Under Special Management now owns 200,000 shares of the company’s stock worth $17,256,000 after buying an additional 108,000 shares in the last quarter.

About VanEck Pharmaceutical ETF

The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.